65. 原発性免疫不全症候群 Primary immunodeficiency Clinical trials / Disease details

臨床試験数 : 482 / 薬物数 : 653 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 212

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05104723 (ClinicalTrials.gov)	March 24, 2022	2/11/2021	Safety and Efficacy of Tofacitinib for Chronic Granulomatous Disease With Inflammatory Complications	A Phase 1/2 Open-label Study to Evaluate the Safety and Efficacy of Tofacitinibfor Chronic Granuloma ...	Chronic Granulomatous Disease;Inflammatory Gastrointestinal Disease;Inflammatory Skin Disease;Inflam ...	Drug: XELJANZ (tofacitinib)	National Institute of Allergy and Infectious Diseases (NIAID)	NULL	Enrolling by invitation	18 Years	N/A	All	20	Phase 1/Phase 2	United States

First Previous1Next Last